Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Julphar
Citi
Merck
UBS
Harvard Business School
Fish and Richardson
Moodys
Medtronic

Generated: February 19, 2018

DrugPatentWatch Database Preview

Par Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for PAR PHARM, and when can generic versions of PAR PHARM drugs launch?

PAR PHARM has two hundred and ten approved drugs.

There is one US patent protecting PAR PHARM drugs on PAR PHARM drugs in the past three years. There are fourteen tentative approvals on PAR PHARM drugs.

There are nine patent family members on PAR PHARM drugs in eight countries and one hundred and twenty supplementary protection certificates in twelve countries.

Summary for Par Pharm
International Patents:9
US Patents:1
Tradenames:126
Ingredients:123
NDAs:210

Drugs and US Patents for Par Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm LAMOTRIGINE lamotrigine TABLET, EXTENDED RELEASE;ORAL 201791-005 Jan 18, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Par Pharm CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 072278-001 May 9, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Par Pharm FENOPROFEN CALCIUM fenoprofen calcium TABLET;ORAL 072429-001 Aug 17, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Par Pharm HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 089145-001 Mar 17, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Par Pharm SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 088933-001 Sep 6, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Par Pharm LAMOTRIGINE lamotrigine TABLET, EXTENDED RELEASE;ORAL 201791-006 Jan 18, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Par Pharm DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062442-001 Dec 22, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Par Pharm AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 078381-001 Jul 29, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Par Pharm Inc MORPHINE SULFATE morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 200812-005 Nov 10, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Par Pharm IBUPROFEN ibuprofen TABLET;ORAL 070328-001 Aug 6, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Par Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm Inc ACCOLATE zafirlukast TABLET;ORAL 020547-001 Sep 26, 1996 4,859,692 ➤ Sign Up
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-003 Approved Prior to Jan 1, 1982 5,238,924 ➤ Sign Up
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995 5,238,924 ➤ Sign Up
Par Pharm NASCOBAL cyanocobalamin GEL, METERED;NASAL 019722-001 Nov 5, 1996 4,724,231 ➤ Sign Up
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-002 Approved Prior to Jan 1, 1982 4,105,776 ➤ Sign Up
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,105,776 ➤ Sign Up
Par Pharm Inc ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 5,482,963 ➤ Sign Up
Par Pharm Inc ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 4,859,692 ➤ Sign Up
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-003 Approved Prior to Jan 1, 1982 4,105,776 ➤ Sign Up
Par Pharm Inc ACCOLATE zafirlukast TABLET;ORAL 020547-001 Sep 26, 1996 5,583,152 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PAR PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Nasal Spray 500 mcg/spray ➤ Subscribe 4/28/2017
➤ Subscribe Tablets 10 mg and 20 mg ➤ Subscribe 2/29/2008

International Patents for Par Pharm Drugs

Supplementary Protection Certificates for Par Pharm Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0043 France ➤ Sign Up PRODUCT NAME: ROSUVASTATIN; NAT. REGISTRATION NO/DATE: NL 28 274 20030611; FIRST REGISTRATION: NL - 26872 20021106
C/GB00/021 United Kingdom ➤ Sign Up PRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316
91023-9 Sweden ➤ Sign Up PRODUCT NAME: ROSUVASTATIN
C/GB98/030 United Kingdom ➤ Sign Up PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204
1920764/01 Switzerland ➤ Sign Up PRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
00241 Netherlands ➤ Sign Up PRODUCT NAME: ENTECAVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF HYDRAAT, IN HET BIJZONDER ENTECAVIRMONOHYDRAAT; REGISTRATION NO/DATE: EU/1/06/343/001-EU/1/06/343/005 20060626
C0021 Belgium ➤ Sign Up PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
2015 00014 Denmark ➤ Sign Up PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
/1997 Austria ➤ Sign Up PRODUCT NAME: TOLCAPONE; REGISTRATION NO/DATE: EU/1/97/044/001 - EU/1/97/044/006 19970827
C0008 Belgium ➤ Sign Up PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
Teva
Chubb
Covington
Chinese Patent Office
Healthtrust
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot